Simpler insulin regimen may work just as well for diabetes
NCT ID NCT05417841
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two ways of taking insulin in people with type 2 diabetes. One group took a mix of long- and fast-acting insulin twice a day. The other group took the mix once a day plus extra fast-acting insulin at meals. After 16 weeks, researchers compared blood sugar control and safety. The goal was to see if the simpler twice-daily schedule is just as effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Insulin degludec and insulin aspart (a mix of long- and fast-acting insulin)
What this could lead to
If successful, this could show that a simpler twice-daily insulin mix works as well as a more complex schedule, making diabetes management easier for patients.
What could go wrong
This is a completed trial with 218 participants, so results are available but not yet widely published. The benefit is about convenience, not a cure, and individual responses may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aerospace general hospital
Beijing, China
-
Beijing Boai Hospital
Beijing, China
-
Beijing Hospital
Beijing, China
-
Hebei General Hospital
Shijiazhuang, Hebei, China
-
Jilin University Sino-Japanese Friendship Hospital
Changchun, Jilin, China
-
Peking university shougang hospital
Beijing, China
-
The Second Affiliated Medical College of Xi'an Jiaotong University
Xi'an, Shaanxi, China